Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study.

MLA

Hirono, Seiichiro, et al. “Oncological and Functional Outcomes of Supratotal Resection of IDH1 Wild-Type Glioblastoma Based on 11C-Methionine PET: A Retrospective, Single-Center Study.” Scientific Reports, vol. 11, no. 1, July 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-021-93986-z.

APA

Hirono, S., Ozaki, K., Kobayashi, M., Hara, A., Yamaki, T., Matsutani, T., & Iwadate, Y. (2021). Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study. Scientific Reports, 11(1), 1–12. https://doi.org/10.1038/s41598-021-93986-z

Chicago

Hirono, Seiichiro, Ko Ozaki, Masayoshi Kobayashi, Ayaka Hara, Tomohiro Yamaki, Tomoo Matsutani, and Yasuo Iwadate. 2021. “Oncological and Functional Outcomes of Supratotal Resection of IDH1 Wild-Type Glioblastoma Based on 11C-Methionine PET: A Retrospective, Single-Center Study.” Scientific Reports 11 (1): 1–12. doi:10.1038/s41598-021-93986-z.